American Standard throws in towel and sells back DiaSorin
This article was originally published in Clinica
Executive Summary
After a brief foray into the medical diagnostics business, American Standard has admitted defeat and has sold its DiaSorin business. It goes to a management buyout backed by an investment banks and the Italian SNIA conglomerate - the same company that sold the diagnostics business to American for $220 million in cash, three years ago (see Clinica No 742, p 1).